These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19929786)

  • 21. l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017.
    Tomczyk MD; Walczak KZ
    Eur J Med Chem; 2018 Nov; 159():393-422. PubMed ID: 30312931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of novel amonafide-polyamine conjugates as anticancer agents.
    Wang Y; Zhang J; Li M; Li M; Xie S; Wang C
    Chem Biol Drug Des; 2017 May; 89(5):670-680. PubMed ID: 27762101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Nitro-naphthalimide and nitrogen mustard conjugate NNM-25 induces hepatocellular carcinoma apoptosis via PARP-1/p53 pathway.
    Xie SQ; Zhang YH; Li Q; Xu FH; Miao JW; Zhao J; Wang CJ
    Apoptosis; 2012 Jul; 17(7):725-34. PubMed ID: 22395446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel C4-benzazole naphthalimide derivatives with potent anti-tumor properties against murine melanoma.
    Lu YT; Chen TL; Chang KS; Chang CM; Wei TY; Liu JW; Hsiao CA; Shih TL
    Bioorg Med Chem; 2017 Jan; 25(2):789-794. PubMed ID: 27939348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterocyclic Naphthalimides as New Skeleton Structure of Compounds with Increasingly Expanding Relational Medicinal Applications.
    Gong HH; Addla D; Lv JS; Zhou CH
    Curr Top Med Chem; 2016; 16(28):3303-3364. PubMed ID: 27150364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, Characterization, Quantum-Chemical Calculations and Cytotoxic Activity of 1,8-Naphthalimide Derivatives with Non-Protein Amino Acids.
    Marinov MN; Naydenova ED; Momekov GT; Prodanova RY; Markova NV; Voynikov YT; Stoyanov NM
    Anticancer Agents Med Chem; 2019; 19(10):1276-1284. PubMed ID: 30848212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
    Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
    Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the development of 1,8-naphthalimide based DNA targeting binders, anticancer and fluorescent cellular imaging agents.
    Banerjee S; Veale EB; Phelan CM; Murphy SA; Tocci GM; Gillespie LJ; Frimannsson DO; Kelly JM; Gunnlaugsson T
    Chem Soc Rev; 2013 Feb; 42(4):1601-18. PubMed ID: 23325367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, anticancer activity and DNA-binding properties of novel 4-pyrazolyl-1,8-naphthalimide derivatives.
    Li S; Xu S; Tang Y; Ding S; Zhang J; Wang S; Zhou G; Zhou C; Li X
    Bioorg Med Chem Lett; 2014 Jan; 24(2):586-90. PubMed ID: 24370011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysosomes-targeting imaging and anticancer properties of novel bis-naphthalimide derivatives.
    Rong RX; Wang SS; Liu X; Li RF; Wang KR; Cao ZR; Li XL
    Bioorg Med Chem Lett; 2018 Feb; 28(4):742-747. PubMed ID: 29342415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intramolecular Aryne-Furan Cycloadditions for the Synthesis of Anticancer Naphthalimides.
    Prévost S; Dezaire A; Escargueil A
    J Org Chem; 2018 Apr; 83(8):4871-4881. PubMed ID: 29596742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: synthesis and biological evaluation.
    Tan S; Han K; Li Q; Tong L; Yang Y; Chen Z; Xie H; Ding J; Qian X; Xu Y
    Eur J Med Chem; 2014 Oct; 85():207-14. PubMed ID: 25084146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A naphthalimide-polyamine conjugate preferentially accumulates in hepatic carcinoma metastases as a lysosome-targeted antimetastatic agent.
    Ma J; Li L; Yue K; Zhang Z; Su S; Chen Y; Yu L; Zhang P; Ma R; Li Y; Ma Y; Jia H; Wang C; Wang J; Xie S
    Eur J Med Chem; 2021 Oct; 221():113469. PubMed ID: 33965862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of naphthalimide-polyamine conjugates modified by alkylation as anticancer agents through p53 pathway.
    Dai F; He H; Xu X; Chen S; Wang C; Feng C; Tian Z; Dong H; Xie S
    Bioorg Chem; 2018 Apr; 77():16-24. PubMed ID: 29316508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
    Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
    Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides.
    Li F; Cui J; Guo L; Qian X; Ren W; Wang K; Liu F
    Bioorg Med Chem; 2007 Aug; 15(15):5114-21. PubMed ID: 17532640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement in intramolecular interactions and in vitro biological activity of a tripodal tetradentate system upon complexation.
    Tyagi N; Viji M; Karunakaran SC; Varughese S; Ganesan S; Priya S; Saneesh Babu PS; Nair AS; Ramaiah D
    Dalton Trans; 2015 Sep; 44(35):15591-601. PubMed ID: 26244289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization of naphthalimide-imidazoacridone with potent antitumor activity leading to clinical candidate (HKH40A, RTA 502).
    Hariprakasha HK; Kosakowska-Cholody T; Meyer C; Cholody WM; Stinson SF; Tarasova NI; Michejda CJ
    J Med Chem; 2007 Nov; 50(23):5557-60. PubMed ID: 17939651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.
    Bagowski CP; You Y; Scheffler H; Vlecken DH; Schmitz DJ; Ott I
    Dalton Trans; 2009 Dec; (48):10799-805. PubMed ID: 20023909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unprecedented synthesis, in vitro and in vivo anti-cancer evaluation of novel triazolonaphthalimide derivatives.
    Li S; Zhong W; Li Z; Meng X
    Eur J Med Chem; 2012 Jan; 47(1):546-52. PubMed ID: 22138307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.